Update: Sell-Off In Biopharmaceutical Stocks- BIIB, PCYC, REGN

purchase Lyrica in canada http://sandiegoapartmentsforsale.com/category/commercial-real-estate/ Big Large Cap Winners Down-Volatilty Increasing

this hyperlink ETFS: IBB $257 down 1.57%, PBE $45.25 down 1.2% , XBI $159.7 down 1.17%

The profit taking which actually began last Friday and, after a brief recovery, resumed yesterday accelerating today. Large caps are leading the way down. Notable losers within the Rayno Portfolio are:

Biogen Idec (BIIB $326.27) down 4.2%, Pharmacyclics (PCYC $131) down 3.3%, Regeneron ($322) down 4.7%.

We recommended going to 15% cash in life science stocks because of huge gains in 2014 YTD.

 

 

No comments yet.

Leave a Reply